Matinas Biopharma
MTNB0.332037.53% ( +0.0906 )
Matinas Biopharma (MTNB)
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC)...
- Open
- 0.3800
- High
- 0.4300
- Low
- 0.3110
- Prev. Close
- 0.2414
- Volume
- 206.25M
- Turnover
- 82.44M
- Avg Price
- 0.3997
- Bid/Ask Ratio
- --
- Amplitude
- 49.30%
- 52wk High
- 3.0900
- Volume Ratio
- 28.51
- Turnover Ratio
- 4,933.93%
Matinas Biopharma Analyst Rating
View MoreForecast & Rating
Apr 30, 2025Price forecast
$30.008936.14%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- US Stock Market Update · 12 hours ago
Matinas BioPharma soars 37% on heavy volume during regular trading
- US Stock Market Update · 15 hours ago
Matinas BioPharma soars 32% intraday on heavy volume
- benzinga_article · 15 hours ago
12 Health Care Stocks Moving In Monday's Intraday Session
- US Stock Market Update · 18 hours ago
Matinas BioPharma surges 37% in regular trading on volume spike
- benzinga_article · 20 hours ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
- TradingView · Jul 24 at 04:03 PM
Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties
